SBRT in oligometastatic castration-resistant prostate cancer.
0/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.6%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
APA
Achard V, Blanchard P, et al. (2025). SBRT in oligometastatic castration-resistant prostate cancer.. The Lancet. Oncology, 26(12), e622. https://doi.org/10.1016/S1470-2045(25)00565-0
MLA
Achard V, et al.. "SBRT in oligometastatic castration-resistant prostate cancer.." The Lancet. Oncology, vol. 26, no. 12, 2025, pp. e622.
PMID
41308683 ↗
같은 제1저자의 인용 많은 논문 (3)
- Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21.
- Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer.
- Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?